3rd Drug Discovery Nexus Summit
The Nexus of Discovery
After record participation by attendees, speakers, sponsors & exhibitors in 2018, we are back with its 3rd edition on 23rd & 24th May 2019 in Munich, Germany. 3rd DDN will feature prominent scientists in both academia & industry to share & discuss the latest advancements in drug discovery. 2019's event will feature new streams, focusing on the latest trends in drug discovery. 3rd DDN will bring together leading experts to discuss challenges from target identification to pre-clinical studies. The event will feature opening and closing plenary keynote sessions, eight conference tracks, interactive breakout discussion groups and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of precise drug discovery.
DAYS
HOURS
MINUTES
SECONDS
About 3rd Drug Discovery Nexus
In this must attend event you can explore the latest drug discovery challenges & hear talks from elocutionists from leading pharma/biotech & academic institutes who are tackling drug discovery challenges.
Peculiar Conference Format
Poster Sessions
Poster sessions will run in parallel with the plenary sessions and possibly during networking breaks. The presenter may deliver a short informal talk or conduct a demonstration.
Pre-qualified one to one meetings
30 minutes pre-qualified meetings is a distinctive feature of the event.
Panel Discussions
Panel discussion will include two to five minute introduction of the topic with each panelist taking five minutes to introduce themselves and their perspectives on the topic. Then 15-20 minutes of Q&A with the audience ending with a summary and thanks.
Exhibition Space
10-12 exhibition booths will be present at the networking area.
Keynote Presentations
30 minutes Keynote presentations will address all the current industry challenges.
Tailor fit & Personalized Agenda
The agenda of the event is carefully researched to ensure that audience is exposed to the highest level of expertise.
What we offer
- Enrich topics
- Meet experts & influencers face to face
- Focused Networking
- Information about the valuable insights of industry
- Virtual synchronization
- Pronouncement Authority
- Distinct Contrast
- Position yourself as an expert
- Direct contact with potential clients and costumers
- Get fresh ideas and solutions for your business
- Stay current with trends by learning from powerful speakers
- Observe visual cues from presenters & other attendees
- Gain insight into how new techniques are being utilized to discover new drugs
-
-
- CSO
- Head, Biology & Translational Pharmacology
- Head, Oncology Chemistry
- Dir Discovery Chemistry & Technology
- Head of Molecular & Computational Toxicology
- VP, R&D
- Director DMPK
- CMO
- Head, Cancer Biology & Pharmacology
- Dir CAR Program, Research & Discovery
- Chief Scientist, R&D
- Director R&D Management
- Director Biomarker Discovery
- Senior Director Preclinical
- Director Pharmacology
- Senior Group Leader Medicinal Chemistry
- VP Preclinical R&D
- VP Chemistry
- Director Preclinical Research
- Director Preclinical Drug Safety
- Head, PTS Discovery Genome Editing
-
- Target identification & validation
- Medicinal Chemistry/Drug Discovery Chemistry
- Chimeric DNA
- NAPDD
- Disease-oriented trials
- Pre-Clinical Accessions
- Disease-Specific sessions
- Modern Drug Discovery
history
2018
Munich, Germany
Drug Discovery NexusProcurement Direct organized Drug Discovery Nexus on 3rd & 4th May 2018 in Munich Germany. Over 200 attendees from top Pharma/Biotech companies attended DDN, the event offered many networking opportunities which our clients perceived useful. Over 15 presentations & two panel discussions on latest Drug Discovery Challenges made DDN a huge success.
3-4 May 2018
18 speakers
130 participants
2018
Boston, USA
2nd Drug Discovery Nexus SummitFollowing positive feedback & enormous success of DDN, Procurement Direct organized 2nd DDN on 25th & 26th October 2018 in Boston USA. Following the success of Munich event, 2nd DDN made a big name in USA industry by ground breaking success. The main distinctive highlight of 2nd DDN was two co-located events which covered the all challenges in USA drug discovery industry. The feedback of clients at 2nd DDN was exceptional.
25 & 26 October 2018
22 speakers
120 participants
2019 Summit
You don’t want to miss this
2 days of inspiration and education on Drug Discovery
- 05/23/2019
- 17 Speakers
- Tickets
meet our speaking talents
Caroline Barelle
CEO, Elasmogen
Geert C. Mudde
CSO and Founder, OncoQR ML
Pascal Mayer
CEO, Alphanosos
Dr Patrizia D\'ALESSIO MD PhD
CEO, AISA Therapeutics
Patrick Jimonet
External Innovation in Drug Discovery, Sanofi,
Matthias Frech
Director, Merck
Werngard Czechtizky
Senior Director, Head Medicinal Chemistry, IMED RIA AstraZeneca
Olaf Ritzeler
Director of scouting external opportunities EUROPE, Sanofi
Christian Schmees
Natural and Medical Sciences Institute, Group Leader Tumor Biology
Stuart Hughes
Director and Head of Pharmacology, Vertex Pharmaceuticals,
Prof. Dr. Johannes Kirchmair
Professor of Applied Bioinformatics, University of Hamburg
Dr. Janina Speck
Group Leader in vitro Display, Roche
Inés Muñoz
Head of Crystallography and Research Center and Protein Engineering Unit, Spanish National Cancer
Lars Neumann
Sr. Dir. Assays, Screening & Biophysics, Proteros
Christel Menet
CSO, Confo Therapeutics
Patrick Baumhof
Vice President Formulation & Delivery, CureVac
Christian Schmees
Group Leader Tumor Biology, Natural and Medical Sciences Institute at University of Tuebingen
In Partnership
Sponsors
World Leaders with us
I have attended Drug Discovery Nexus 2018. It was very interesting conference. It has lot of high values talks also the venue of the conference was very nice, there was much possibilities to network & learn new contacts, I think there will be some follow ups that I have already discovered & I really like the conference.
I was very pleased to come here & I think it was very interesting conference, I learned a lot & I hope to create some collaborative relationships with people from this audience. Thank you very much to organizers, it was a really a pleasure to be here.
First of all I would like to congratulate to organization committee to put this kind of event that I see is very very interesting because it is one opportunity to put altogether different brands, different collaborations that are present in all over the world & I think it is big opportunity to discuss about different needs with all the colleagues in a very friendly environment that organized by Procurement Direct & I see that I really enjoy a lot this meeting, I congratulate to them & I hope to join in the future.
I have found very interesting contacts and information about the equipment concerning testing the phenotype of cells we are producing
I think it was a great meeting, great conference and we had plenty of time for networking & follow the value chain on beginning with strategic decisions how to come to work on the disease on the target following up this modalities & new technologies which can be very helpful on to advance through different stages fast & high probability of success & it was great opportunity to meet colleague friends & we have discussions on subjects which have very importance in rare diseases & also drug discovery in general.
View our gallery
Gallery
Because the images speak more than words
